# Georgia Clinical & Translational Science Alliance (GaCTSA)

> **NIH NIH UL1** · EMORY UNIVERSITY · 2021 · $8,523,526

## Abstract

The Georgia Clinical and Translational Science Alliance (GaCTSA) is a compelling partnership of
Emory University, Morehouse School of Medicine, the Georgia Institute of Technology and the University of
Georgia, a new academic member adding resources and assets to our CTSA. Also key to GaCTSA are our
healthcare partners: Emory Healthcare, Morehouse Healthcare, Children’s Healthcare of Atlanta, the Atlanta
VA Medical Center, the Grady Health System, and the Atlanta Community Physicians Network and our
translational science partners including the Yerkes National Primate Research Center (located at Emory), the
Georgia Research Alliance, Georgia Bio and links to the Prevention Research Centers of the US Centers for
Disease Control and Prevention (CDC). Built over the past decade of collaboration, the partners of GaCTSA
have forged strong research networks and GaCTSA has become a “24 hour” home and catalyst for innovative,
high quality clinical and translational research with local, national and global impact. The addition of UGA
allows the GaCTSA to better engage the large, rural and underserved populations of our state and adds new
resources, including: outstanding translational research in glycobiology, infectious diseases, One Health, a
new clinical and translational research unit, outstanding programs in Education, a School of Pharmacy; a
robust extension service that reaches beyond its original agricultural mission to focus on family health; and the
Archway Partnership whose mission is to connect Georgia communities with higher education resources to
address critical, locally identified community needs. In addition to facilitating innovative science, GaCTSA will
encourage collaboration, improve quality and efficiencies, reduce barriers to clinical and translational research
and accelerate the process of translating biomedical discoveries into clinical applications. Key to the next
funding cycle, GaCTSA will emphasize innovative training and workforce development, access to and
integration of special and underserved populations, enhanced biomedical informatics support and capabilities,
new methods and processes to improve quality and efficiency, enhanced collaboration and engagement and
team-based, quality focused predictive science. The specific aims of GaCTSA reflect the vision and goals of
NCATS Advisory Council Working Group and the recommendations of the 2013 IOM review of the CTSA
program. The GaCTSA’s specific aims will serve as guiding principles to drive the vision and approach.

## Key facts

- **NIH application ID:** 10210461
- **Project number:** 5UL1TR002378-05
- **Recipient organization:** EMORY UNIVERSITY
- **Principal Investigator:** Andres J Garcia
- **Activity code:** UL1 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $8,523,526
- **Award type:** 5
- **Project period:** 2017-09-22 → 2022-08-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10210461

## Citation

> US National Institutes of Health, RePORTER application 10210461, Georgia Clinical & Translational Science Alliance (GaCTSA) (5UL1TR002378-05). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10210461. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*